Feature
Companies pioneer 'materials as a service' using techniques created at Imperial
Innovative material suppliers are looking to retain ownership over the metals and chemicals they supply as a new sustainable business model takes off.
Academia in the UK is 'like oil to middle east,' says leading venture capitalist
The UK scientific community should take advantage of its expertise by building more home-grown tech companies urged industry leader Alexis Dormandy.
Spinouts join forces on technology to accelerate electric vehicle development
Electric vehicle makers could save up to 18 months development time using technology under development by Imperial spinouts About:Energy and Monolith.
EnAcuity to develop visualisation technology for minimally invasive surgery
A new spinout company from Imperial and UCL has received pre-seed funding to develop AI technology that could aid laparoscopic surgery.
AI spinout Polaron to accelerate design of advanced materials
A new Imperial spinout company will use generative AI to help companies design higher performing materials for applications such as batteries.
New centre to develop sustainable materials for steel industry of the future
New centre will see Imperial and Tata Steel partner to develop innovative new manufacturing processes to help decarbonise steel production.
Imperial AI initiative I-X to collaborate with Fetch.ai on ‘new AI economy'
AI startup Fetch.ai has joined I-X Business Partners, the corporate membership programme of Imperial’s flagship initiative in artificial intelligence.
Research with AMD to optimise computer hardware for AI
Imperial is working with the semiconductor company AMD to optimise computer processors for machine learning.
Imperial President - College making big moves to accelerate medical innovation
Professor Hugh Brady says that Imperial is working to speed development of innovations that have potential to be as transformational as penicillin.
Apollo Therapeutics raises $226.5m to develop medicines based on uni research
Company founded by the tech transfer offices of Imperial, Cambridge and UCL has raised major Series C funding to turn basic research into medicines.
